INS and type 1 diabetes mellitus: Indomethacin could not only stimulate the production of endogenous glucose in T2DM patients by inhibiting insulin secretion,229 but also reduced the increase of albumin excretion rate in T1DM patients with microalbuminuria by inhibiting renal prostaglandin synthesis.230